Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
35 participants
OBSERVATIONAL
2006-06-30
2013-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optimal Stent Selection for the Femoropopliteal Artery
NCT02602145
The Research About the ACS After Femoropopliteal Arterial Injuries
NCT05030259
Viennese Registry on Patients With Chronic Critical Limb Ischemia
NCT01233141
Peripheral Microvascular Resistance as a Predictor for Limb Salvage
NCT06014242
Angio-seal VIP Versus Perclose ProGlide for Closure of the Femoral Artery in Peripheral Vascular Disease
NCT05334095
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No history of core decompression
* Patient is willing and able to provide written informed consent
Exclusion Criteria
* Patient's BMI is \>40
* Patient is mentally compromised
* Patient has neurological condition in ipsilateral or contralateral limb, which affect lower limb function
* The patient has had a proximal femoral osteotomy or internal fixation in the affected hip.
* The patient has undergone previous treatment for AVN
* Previous hip conditions
* Patient's bone stock is insufficient
* Patient has diagnosed systemic disease
* Patient is a pregnant female
* Patient is unable or unwilling to attend postop follow-up visits
* Patient has received investigational drug within the previous 6 months or an investigational device within the last 12 months
* Patient has an active or latent infection
* Patient has metal sensitivity
* Patient is a prisoner
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zimmer Biomet
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Emory Orthopedic Clinic
Atlanta, Georgia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IC006-99
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.